rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Hims & Hers Health, Inc.

HIMS · NYSE

Health CareDigital Health & TelemedicineSetting upGLP-1

HIMS stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 0.8% below that average now. Digital Health & Telemedicine: 20% of its 5 stocks in an uptrend (±0 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 1
Industry in uptrend
20% 0 in 4 wk
Insider buys, 12 months
$2.3M
Insider sales, 12 months
$35.0M
Officials’ trades on record
1
Institutions holding
472 (+72)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

17 Apr – 16 Oct
1%20%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Digital Health & Telemedicine: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$44.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k4 Aug 2025filed 12 Sep 2025

Insiders

Buy orders, 12 months1
Sale orders, 12 months46
Buyers · sellers1 · 8
WhoDidSharesTraded
Soleil BoughtonChief Legal Officersold3,461at $29.0614 Oct 2026filed 15 Oct 2026
Oluyemi OkupeChief Financial Officersold2,000at $29.701 Oct 2026filed 2 Oct 2026
Soleil BoughtonChief Legal Officersold3,461at $29.1730 Sep 2026filed 2 Oct 2026
Oluyemi OkupeChief Financial Officersold29,277at $29.9522 Sep 2026filed 23 Sep 2026
Oluyemi OkupeChief Financial Officersold12,313at $28.8217 Sep 2026filed 18 Sep 2026
Soleil BoughtonChief Legal Officersold6,236at $27.8616 Sep 2026filed 17 Sep 2026
Michael ChiChief Operating Officersold14,027at $28.3915 Sep 2026filed 17 Sep 2026
Mohamed ElshenawyCTOsold7,954at $28.3915 Sep 2026filed 17 Sep 2026
Soleil BoughtonChief Legal Officersold3,458at $28.332 Sep 2026filed 3 Sep 2026
Soleil BoughtonChief Legal Officersold25,111at $27.5519 Aug 2026filed 20 Aug 2026
Oluyemi OkupeChief Financial Officersold4,938at $29.9919 Aug 2026filed 20 Aug 2026
Deborah M. AutorChief Policy Officersold16,773at $27.8518 Aug 2026filed 20 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders472+72 on the quarter
New · exited138 · 65
Reported value$5.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202628,703,514$995.2M+2,366,356+9.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202610,559,314$366.1M+375,501+3.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20269,541,384$330.8M+201,673+2.2%
STATE STREET CORPadded · filed 7 Aug 20268,145,699$282.4M+685,676+9.2%
MORGAN STANLEYreduced · filed 13 Aug 20267,152,498$248.0M-1,736,590−19.5%
Divisadero Street Capital Management, LPadded · filed 14 Aug 20266,009,505$208.3M+5,539,672+1179.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20265,681,832$197.0M+483,053+9.3%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20265,173,865$179.4M+2,719,170+110.8%
JPMORGAN CHASE & COnew · filed 12 Aug 20264,766,781$159.5M+4,766,781
FMR LLCadded · filed 13 Aug 20264,323,292$149.9M+4,230,022+4535.2%
31 Mar 2023 – 30 Jun 2026
169317465Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Soleil Boughton Company insiderChief Legal Officer · last 14 Oct 20260 · 83
Oluyemi Okupe Company insiderChief Financial Officer · last 1 Oct 20261 · 61
Michael Chi Company insiderChief Operating Officer · last 15 Sep 20260 · 50
Mohamed Elshenawy Company insiderCTO · last 15 Sep 20260 · 2
Andrew Dudum Company insiderChief Executive Officer · last 27 Aug 20262 · 64
Deborah M. Autor Company insiderChief Policy Officer · last 18 Aug 20260 · 2
Christopher D. Payne Company insiderDirector · last 14 Aug 20261 · 0
David B. Wells Company insiderDirector · last 14 Aug 20265 · 3
Irene Becklund Company insiderPAO · last 14 Aug 20260 · 43
Kare Schultz Company insiderDirector · last 14 Aug 20260 · 0
Patrick Harrison Carroll Company insiderChief Medical Officer · last 14 Aug 20260 · 13
Anja Manuel Company insiderDirector · last 12 Aug 20262 · 0

Same industry

DOCS DoximityJust started moving+30%
PHR PhreesiaAbove a falling average+7%
TDOC Teladoc HealthNot moving yet-16%
LFMD LifeMDNot moving yet-40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202573.8%
Operating profit marginFY 2025 · to 31 Dec 20254.5%
Free cash flow marginFY 2025 · to 31 Dec 20252.4%
Return on capital employedFY 2025 · to 31 Dec 20256.0%
Cash conversionFY 2025 · to 31 Dec 2025234%
Cash and equivalentsFY 2025 · to 31 Dec 2025$228.6M
Free cash flowFY 2025 · to 31 Dec 2025$57.4M

Analyst forecasts

No analyst forecasts yet.